| ATTR-CM: A Multi-country, Non-interventional Disease Registry (NCT06651073) | Pfizer | 2024-10-01 |
| SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS (NCT06482099) | Pfizer | 2024-10-01 |
| A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain. (NCT06075615) | Pfizer | 2024-09-30 |
| A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults (NCT06659250) | Pfizer | 2024-09-27 |
| A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH) (NCT06462235) | Pfizer | 2024-09-25 |
| An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis (NCT06398626) | Pfizer | 2024-09-17 |
| A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883. (NCT06586216) | Pfizer | 2024-09-10 |
| A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. (NCT06546553) | Pfizer | 2024-09-06 |
| A Study to Learn How the Medicine Called [14C] PF-06821497 is Taken up Into and Removed From the Body. (NCT06392230) | Pfizer | 2024-08-30 |
| A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese (NCT06567327) | Pfizer | 2024-08-28 |
| A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies (NCT06592222) | Pfizer | 2024-08-26 |
| Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy (NCT06647654) | Pfizer | 2024-08-26 |
| A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity (NCT06568731) | Pfizer | 2024-08-23 |
| A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib) (NCT05912933) | Pfizer | 2024-08-19 |
| A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib) (NCT05709158) | Pfizer | 2024-08-19 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults. (NCT06532383) | Pfizer | 2024-08-14 |
| Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib (NCT06531109) | Pfizer | 2024-08-07 |
| Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use. (NCT06479954) | Pfizer | 2024-07-30 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Children (NCT06531538) | Pfizer | 2024-07-30 |
| To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults (NCT06593054) | Pfizer | 2024-07-29 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Infants (NCT06524414) | Pfizer | 2024-07-25 |
| A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause (NCT06465368) | Pfizer | 2024-07-11 |
| A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults (NCT06466473) | Pfizer | 2024-07-03 |
| A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults. (NCT06467370) | Pfizer | 2024-07-02 |
| A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer. (NCT06321510) | Pfizer | 2024-07-01 |
| A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. (NCT06447662) | Pfizer | 2024-06-27 |
| A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer (NCT06495164) | Pfizer | 2024-06-24 |
| A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults. (NCT06473519) | Pfizer | 2024-06-24 |
| Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone (NCT05509894) | Pfizer | 2024-06-20 |
| Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) (NCT06353087) | Pfizer | 2024-06-19 |
| Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy (NCT06393465) | Pfizer | 2024-06-15 |
| A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users. (NCT06532357) | Pfizer | 2024-06-09 |
| A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanercept Administration in Rheumatoid Arthritis (NCT05891600) | Pfizer | 2024-06-06 |
| A STUDY TO LEARN HOW THE STUDY MEDICINE CALLED PF-07293893 AFFECTS MUSCLE BIOMARKERS OF HEALTHY ADULTS (NCT06413693) | Pfizer | 2024-05-23 |
| A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis (NCT06418529) | Pfizer | 2024-05-15 |
| A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin (NCT06327880) | Pfizer | 2024-05-13 |
| A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination (NCT06448364) | Pfizer | 2024-05-09 |
| A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis (NCT06294925) | Pfizer | 2024-05-08 |
| A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of Healthy Male Adults When Taken With or Without Food (NCT06369454) | Pfizer | 2024-05-03 |
| A Study to Learn About the Safety of PENBRAYA During Pregnancy (NCT07768163) | Pfizer | 2024-05-03 |
| A Study to Learn How Different Forms of the Study Medicine Called PF-06954522 Are Taken up Into the Blood in Healthy Adults (NCT06393517) | Pfizer | 2024-04-30 |
| A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function (NCT06340347) | Pfizer | 2024-04-30 |
| Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis (NCT05754710) | Pfizer | 2024-04-12 |
| A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco (NCT05997485) | Pfizer | 2024-03-30 |
| A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India (NCT06086353) | Pfizer | 2024-03-25 |
| A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) (NCT06321523) | Pfizer | 2024-03-19 |
| A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain. (NCT06291831) | Pfizer | 2024-03-13 |
| A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants (NCT06325657) | Pfizer | 2024-03-12 |
| A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark. (NCT06307457) | Pfizer | 2024-03-06 |
| Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years (NCT06130410) | Pfizer | 2024-03-06 |
| Litfulo Capsules Special Investigation (NCT06279221) | Pfizer | 2024-03-01 |
| A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults (NCT06273839) | Pfizer | 2024-02-27 |
| A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant (NCT06275841) | Pfizer | 2024-02-23 |
| ATGAM General Investigation (NCT06039020) | Pfizer | 2024-02-21 |
| A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus (NCT06279234) | Pfizer | 2024-02-20 |
| A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30) (NCT06215118) | Pfizer | 2024-02-20 |
| A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. (NCT06206837) | Pfizer | 2024-02-19 |
| A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea (NCT05733104) | Pfizer | 2024-02-19 |
| A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV (NCT06102174) | Pfizer | 2024-02-15 |
| A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam (NCT06256510) | Pfizer | 2024-02-08 |
| MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) (NCT06152575) | Pfizer | 2024-02-08 |
| A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors (NCT06285097) | Pfizer | 2024-02-08 |
| A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults (NCT06172348) | Pfizer | 2024-02-01 |
| A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults (NCT06237049) | Pfizer | 2024-01-31 |
| A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults (NCT06267963) | Pfizer | 2024-01-31 |
| A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo (NCT06163326) | Pfizer | 2024-01-19 |
| A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza. (NCT06163677) | Pfizer | 2024-01-17 |
| Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. (NCT05905341) | Pfizer | 2024-01-15 |
| A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults (NCT06190561) | Pfizer | 2024-01-15 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) (NCT06125522) | Pfizer | 2024-01-10 |
| A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment (NCT06105632) | Pfizer | 2024-01-09 |
| Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine (NCT06412965) | Pfizer | 2024-01-02 |
| A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone (NCT06113952) | Pfizer | 2024-01-01 |
| A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma (NCT06205407) | Pfizer | 2023-12-26 |
| A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult Participants (NCT06177457) | Pfizer | 2023-12-20 |
| A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults (NCT06182124) | Pfizer | 2023-12-20 |
| A Sub Study to Evaluate the Study Medication (Etrasimod) Using Wearable Sensors in Healthy Participants (NCT06140290) | Pfizer | 2023-12-20 |
| A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza (NCT06179446) | Pfizer | 2023-12-13 |
| A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection (NCT06079320) | Pfizer | 2023-12-08 |
| A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia (NCT05189639) | Pfizer | 2023-12-05 |
| A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults (NCT05989048) | Pfizer | 2023-11-29 |
| A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19 (NCT05890612) | Pfizer | 2023-11-29 |
| Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults (NCT06153758) | Pfizer | 2023-11-27 |
| A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers (NCT06122194) | Pfizer | 2023-11-23 |
| A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces (NCT06151418) | Pfizer | 2023-11-22 |
| A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults (NCT06137729) | Pfizer | 2023-11-17 |
| A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension (NCT06137742) | Pfizer | 2023-11-17 |
| A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 (NCT06072183) | Pfizer | 2023-11-08 |
| A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers (NCT06116591) | Pfizer | 2023-11-08 |
| A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19. (NCT06085924) | Pfizer | 2023-11-07 |
| A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults. (NCT05987072) | Pfizer | 2023-11-03 |
| A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults. (NCT06105983) | Pfizer | 2023-11-03 |
| A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease (NCT06077968) | Pfizer | 2023-11-01 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults (NCT06106009) | Pfizer | 2023-10-27 |
| Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data (NCT05876377) | Pfizer | 2023-10-23 |
| A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants (NCT05960032) | Pfizer | 2023-10-23 |
| A Study to Learn About the Study Medicine - Precedex in Children From Japan. (NCT06085573) | Pfizer | 2023-10-18 |
| A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia (NCT06016556) | Pfizer | 2023-10-17 |
| A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs (NCT06003114) | Pfizer | 2023-10-06 |
| A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (NCT06072196) | Pfizer | 2023-10-04 |